Download
s00395-021-00899-z.pdf 3,14MB
WeightNameValue
1000 Titel
  • Prevention of vascular calcification by the endogenous chromogranin A-derived mediator that inhibits osteogenic transdifferentiation
1000 Autor/in
  1. Orth-Alampour, Setareh |
  2. Gayrard, Nathalie |
  3. Salem, Silvia |
  4. Bhargava, Shruti |
  5. Jankowski, Vera |
  6. Jover, Bernard |
  7. Notarnicola, Cécile |
  8. Noels, Heidi |
  9. van der Vorst, Emiel P. C. |
  10. Kuppe, Christoph |
  11. Wolf, Michael |
  12. Goettsch, Claudia |
  13. Theelen, Wendy |
  14. Bruck, Heike |
  15. Fliser, Danilo |
  16. Loscalzo, Joseph |
  17. Wu, Zhuojun |
  18. Marx, Nikolaus |
  19. Zidek, Walter |
  20. Argilés, Àngel |
  21. Jankowski, Joachim |
1000 Erscheinungsjahr 2021
1000 Publikationstyp
  1. Artikel |
1000 Online veröffentlicht
  • 2021-10-13
1000 Erschienen in
1000 Quellenangabe
  • 116(1):57
1000 Copyrightjahr
  • 2021
1000 Lizenz
1000 Verlagsversion
  • https://doi.org/10.1007/s00395-021-00899-z |
  • https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8514386/ |
1000 Publikationsstatus
1000 Begutachtungsstatus
1000 Sprache der Publikation
1000 Abstract/Summary
  • The adrenal glands participate in cardiovascular (CV) physiology and the pathophysiology of CV diseases through their effects on sodium and water metabolism, vascular tone and cardiac function. In the present study, we identified a new adrenal compound controlling mesenchymal cell differentiation that regulates osteoblastic differentiation in the context of vascular calcification. This peptide was named the 'calcification blocking factor' (CBF) due to its protective effect against vascular calcification and is released from chromogranin A via enzymatic cleavage by calpain 1 and kallikrein. CBF reduced the calcium content of cells and thoracic aortic rings under calcifying culture conditions, as well as in aortas from animals treated with vitamin D and nicotine (VDN animals). Furthermore, CBF prevented vascular smooth muscle cell (VSMC) transdifferentiation into osteoblast-like cells within the vascular wall via the sodium-dependent phosphate transporter PIT-1 and by inhibition of NF-κB activation and the subsequent BMP2/p-SMAD pathway. Pulse pressure, a marker of arterial stiffness, was significantly decreased in VDN animals treated with CBF. In line with our preclinical data, CBF concentration is significantly reduced in diseases characterized by increased calcification, as shown in patients with chronic kidney disease. In preparation for clinical translation, the active site of the native 19-AS long native CBF was identified as EGQEEEED. In conclusion, we have identified the new peptide CBF, which is secreted from the adrenal glands and might prevent vascular calcification by inhibition of osteogenic transdifferentiation. The anti-calcific effects of CBF and short active site may therefore promote the development of new tools for the prevention and/or treatment of vascular calcification.
1000 Sacherschließung
lokal Muscle, Smooth, Vascular [MeSH]
lokal Vascular calcification
lokal Humans [MeSH]
lokal Original Contribution
lokal Vascular Calcification/prevention
lokal Animals [MeSH]
lokal Vascular smooth muscle cell transdifferentiation
lokal Cell Transdifferentiation [MeSH]
lokal Chromogranin A [MeSH]
lokal Cardiorenal syndrome
lokal Cells, Cultured [MeSH]
lokal Myocytes, Smooth Muscle [MeSH]
lokal Adrenal glands
1000 Liste der Beteiligten
  1. https://frl.publisso.de/adhoc/uri/T3J0aC1BbGFtcG91ciwgU2V0YXJlaA==|https://frl.publisso.de/adhoc/uri/R2F5cmFyZCwgTmF0aGFsaWU=|https://frl.publisso.de/adhoc/uri/U2FsZW0sIFNpbHZpYQ==|https://frl.publisso.de/adhoc/uri/QmhhcmdhdmEsIFNocnV0aQ==|https://frl.publisso.de/adhoc/uri/SmFua293c2tpLCBWZXJh|https://frl.publisso.de/adhoc/uri/Sm92ZXIsIEJlcm5hcmQ=|https://frl.publisso.de/adhoc/uri/Tm90YXJuaWNvbGEsIEPDqWNpbGU=|https://frl.publisso.de/adhoc/uri/Tm9lbHMsIEhlaWRp|https://frl.publisso.de/adhoc/uri/dmFuIGRlciBWb3JzdCwgRW1pZWwgUC4gQy4=|https://frl.publisso.de/adhoc/uri/S3VwcGUsIENocmlzdG9waA==|https://frl.publisso.de/adhoc/uri/V29sZiwgTWljaGFlbA==|https://frl.publisso.de/adhoc/uri/R29ldHRzY2gsIENsYXVkaWE=|https://frl.publisso.de/adhoc/uri/VGhlZWxlbiwgV2VuZHk=|https://frl.publisso.de/adhoc/uri/QnJ1Y2ssIEhlaWtl|https://frl.publisso.de/adhoc/uri/Rmxpc2VyLCBEYW5pbG8=|https://frl.publisso.de/adhoc/uri/TG9zY2Fsem8sIEpvc2VwaA==|https://frl.publisso.de/adhoc/uri/V3UsIFpodW9qdW4=|https://frl.publisso.de/adhoc/uri/TWFyeCwgTmlrb2xhdXM=|https://frl.publisso.de/adhoc/uri/WmlkZWssIFdhbHRlcg==|https://frl.publisso.de/adhoc/uri/QXJnaWzDqXMsIMOAbmdlbA==|https://orcid.org/0000-0002-4528-2967
1000 Hinweis
  • DeepGreen-ID: fe39abe9de844230bd6b42b80d16b7f7 ; metadata provieded by: DeepGreen (https://www.oa-deepgreen.de/api/v1/), LIVIVO search scope life sciences (http://z3950.zbmed.de:6210/livivo), Crossref Unified Resource API (https://api.crossref.org/swagger-ui/index.html), to.science.api (https://frl.publisso.de/), ZDB JSON-API (beta) (https://zeitschriftendatenbank.de/api/), lobid - Dateninfrastruktur für Bibliotheken (https://lobid.org/resources/search)
1000 Label
1000 Dateien
1000 Objektart article
1000 Beschrieben durch
1000 @id frl:6450744.rdf
1000 Erstellt am 2023-05-11T10:52:52.144+0200
1000 Erstellt von 322
1000 beschreibt frl:6450744
1000 Zuletzt bearbeitet Sat Oct 21 03:58:35 CEST 2023
1000 Objekt bearb. Sat Oct 21 03:58:35 CEST 2023
1000 Vgl. frl:6450744
1000 Oai Id
  1. oai:frl.publisso.de:frl:6450744 |
1000 Sichtbarkeit Metadaten public
1000 Sichtbarkeit Daten public
1000 Gegenstand von

View source